Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States

View ORCID ProfileFarhaan S. Vahidy, View ORCID ProfileLauren Pischel, Mauricio E. Tano, Alan P. Pan, Marc L. Boom, Henry Dirk Sostman, Khurram Nasir, Saad B. Omer
doi: https://doi.org/10.1101/2021.04.21.21255873
Farhaan S. Vahidy
1Center for Outcomes Research, Houston Methodist, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Farhaan S. Vahidy
  • For correspondence: fvahidy@houstonmethodist.org
Lauren Pischel
2Yale School of Medicine, Department of Medicine, Section of Infectious Diseases, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lauren Pischel
Mauricio E. Tano
1Center for Outcomes Research, Houston Methodist, Houston, TX
3Department of Nuclear Engineering, Texas A&M University, College Station, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan P. Pan
1Center for Outcomes Research, Houston Methodist, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc L. Boom
4Houston Methodist Academic Institute, Houston Methodist, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Dirk Sostman
4Houston Methodist Academic Institute, Houston Methodist, Houston, TX
5Weill Cornell Medicine, Weill Cornell, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khurram Nasir
1Center for Outcomes Research, Houston Methodist, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saad B. Omer
2Yale School of Medicine, Department of Medicine, Section of Infectious Diseases, New Haven, CT
6Yale School of Public Health, New Haven, CT
7Yale Institute of Global Health, New Haven, CT
8Yale School of Nursing, Orange, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Covid-19 has caused significant global mortality. Multiple vaccines have demonstrated efficacy in clinical trials though real-world effectiveness of vaccines against Covid-19 mortality in clinically and demographically diverse populations has not yet been reported.

Methods We used a retrospective cohort assembled from a cross-institution comprehensive data repository. Established patients of the health care system were categorized as not immunized, partially immunized, or fully immunized against SARS-CoV-2 with an mRNA vaccine through April 4, 2021. Outcomes were Covid-19 related hospitalization and death.

Results Of the 91,134 established patients, 70.2% were not immunized, 4.5% were partially immunized and 25.4% were fully immunized. Among the fully immunized 0.7% had a Covid-19 hospitalization, whereas 3.4% among the partially immunized and 2.7% non-immunized individuals were hospitalized with Covid-19. Of the 225 deaths among Covid-19 hospitalizations, 219 (97.3%) were in the not immunized, 5 (2.2%) in the partially immunized, and 1 (0.0041%) in the fully immunized group. mRNA vaccines were 96% (95%CI: 95 — 99) effective at preventing Covid-19 related hospitalization and 98.7% (95%CI: 91.0 — 99.8) effective at preventing Covid-19 related death when participants were fully vaccinated. Partial vaccination was 77% (95%CI: 71 — 82) effective at preventing hospitalization and 64.2% (95%CI: 13.0 — 85.2) effective at preventing death. Vaccine effectiveness at preventing hospitalization was conserved across subgroups of age, race, ethnicity, Area Deprivation Index, and Charlson Comorbidity Index.

Conclusions In a large, diverse cohort in the United States, full immunization with mRNA vaccines was highly effective in the real-world scenario at preventing Covid-19 related hospitalization and death.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Financial support for the COVID-19 Surveillance and Outcomes Registry (CURATOR) was provided by Houston Methodist and the Houston Methodist Academic Institute. The study was partially funded by the Yale Institute for Global Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Houston Methodist Institutional Review Board (PRO 00025445:1)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • COI: The authors do not report any conflicts of interest,

Data Availability

Data are collected under the Houston Methodist IRB approved project, CURATOR. Reasonable requests for a fully de-identified dataset can be made to the corresponding author. These requests will be evaluated on an individual basis by the CURATOR governance committee and the IRB.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States
Farhaan S. Vahidy, Lauren Pischel, Mauricio E. Tano, Alan P. Pan, Marc L. Boom, Henry Dirk Sostman, Khurram Nasir, Saad B. Omer
medRxiv 2021.04.21.21255873; doi: https://doi.org/10.1101/2021.04.21.21255873
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States
Farhaan S. Vahidy, Lauren Pischel, Mauricio E. Tano, Alan P. Pan, Marc L. Boom, Henry Dirk Sostman, Khurram Nasir, Saad B. Omer
medRxiv 2021.04.21.21255873; doi: https://doi.org/10.1101/2021.04.21.21255873

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8786)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1863)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10563)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1755)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (265)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1844)
  • Public and Global Health (3985)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)